Singapore-based traditional Chinese medicine (TCM) company Eu Yan Sang International will be acquired by Japan's Mitsui and Rohto Pharmaceutical in a deal valued at S$800 million. The company has grown from a small shop in Perak to more than 170 stores across Asia in 144 years.
Singapore -based traditional Chinese medicine company Eu Yan Sang International will be acquired by Japan's Mitsui and Rohto Pharmaceutical in a deal valued at S$800 million.will be acquired
Eu Tong Sen established himself in Malaya and Singapore and became a prominent figure in tin mining and rubber plantation businesses by the 1920s."As he expanded the medical shop beyond Gopeng, he decided to brand the medical business more firmly with the attachment of the family name, and his medical shops were named Eu Yan Sang since then," the company wrote on its website.
Following Eu Tong Sen's death in 1941, his fortune was divided among his 13 sons. The business became too complex to govern after his death, and most of his assets were sold off by the 1980s, reported the South China Morning Post in 2017. Three years later, Richard Eu and three of his cousins staged a buyout of the pharmaceutical arm of the company at a sum of S$21 million, and formed Eu Yan Sang International Holdings.
In 2000, Eu Yan Sang International was publicly listed on the Singapore Exchange . The following year, it launched TCM clinics in Malaysia and Singapore.In August 2016, the company reported a full-year net loss of S$13.5 million. In China, the group closed its food and beverage business and six retail outlets.
The company has more than 170 retail stores in China, Hong Kong, Macao, Malaysia and Singapore, with 30 TCM clinics in Singapore, Malaysia, Hong Kong and China. It also has an F&B outlet in Malaysia.
Singapore TCM Eu Yan Sang Mitsui Rohto Pharmaceutical Acquisition Traditional Chinese Medicine Asia
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Singapore's Eu Yan Sang to be acquired by Mitsui, Rohto Pharmaceutical for US$594 millionSINGAPORE: Japan's Mitsui & Co said on Thursday (Apr 4) it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million (US$594 million).
Read more »
Eu Yan Sang to be acquired by Japan's Mitsui, Rohto Pharmaceutical for S$800 millionSINGAPORE — Japan's Mitsui & Co said on Thursday (April 4) it had teamed up with Rohto Pharmaceutical to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicine firm at S$800 million.
Read more »
Japanese firms to buy out traditional Chinese medicine maker Eu Yan SangJapanese trading house Mitsui & Co and Rohto Pharmaceutical are set to acquire 86% of Eu Yan Sang, a local traditional Chinese medicine maker, for US$594 million.
Read more »
Eu Yan Sang to be acquired by Japan’s Mitsui, Rohto Pharmaceutical for $800mA special purpose entity will buy around 86 per cent of the TCM maker from Righteous Crane Holding.
Read more »
Eu Yan Sang to be acquired by Japan's Rohto Pharma, Mitsui for $800mOne of Singapore's oldest homegrown brands Eu Yan Sang will be acquired by Japan's Rohto Pharmaceutical and Mitsui & Co. The deal for the 144-year-old Traditional Chinese Medicine firm is valued at $800 million.
Read more »
Singapore Discovery Centre becomes first energy-positive museum in SingaporeThe Singapore Discovery Centre is the first museum in Singapore to generate more electricity than it consumes. The decades-old attraction became energy-positive after generating about 30 per cent more energy on average than it needed from October to February.
Read more »